Does TOFACITINIB Cause Nasopharyngitis? 7,781 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 7,781 reports of Nasopharyngitis have been filed in association with TOFACITINIB (XELJANZ XR). This represents 5.0% of all adverse event reports for TOFACITINIB.
7,781
Reports of Nasopharyngitis with TOFACITINIB
5.0%
of all TOFACITINIB reports
1,285
Deaths
2,049
Hospitalizations
How Dangerous Is Nasopharyngitis From TOFACITINIB?
Of the 7,781 reports, 1,285 (16.5%) resulted in death, 2,049 (26.3%) required hospitalization, and 1,386 (17.8%) were considered life-threatening.
Is Nasopharyngitis Listed in the Official Label?
Yes, Nasopharyngitis is listed as a known adverse reaction in the official FDA drug label for TOFACITINIB.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Nasopharyngitis?
ADALIMUMAB (13,753)
ETANERCEPT (12,421)
METHOTREXATE (8,046)
SECUKINUMAB (7,022)
TOCILIZUMAB (6,664)
RITUXIMAB (6,321)
ABATACEPT (6,143)
INFLIXIMAB (5,353)
CERTOLIZUMAB PEGOL (5,295)
DUPILUMAB (5,047)
Which TOFACITINIB Alternatives Have Lower Nasopharyngitis Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN